Amalgamated Bank’s SQZ Biotechnologies Company SQZ Stock Holding History

Amalgamated Bank’s Portfolio SQZ Stock Details SQZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,753	Closed	-$13K	–	3286
2022 Q1	$13K	Buy	+2,753	New	+$17.5K	﹤0.01%	2919

Other funds holding SQZ

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's SQZ Position: Q2 2022 in Review

Amalgamated Bank sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 2,753 shares — an estimated $13K sold.

Amalgamated Bank first reported a position in SQZ in Q1 2022 and held it in 1 quarter. The position peaked at $13K in Q1 2022. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

Amalgamated Bank reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 2,753 SQZ Biotechnologies Company shares in Q2 2022, an estimated $13K.
Amalgamated Bank first reported a position in SQZ Biotechnologies Company in Q1 2022 and held it in 1 quarter.
Amalgamated Bank's SQZ Biotechnologies Company position peaked at $13K in Q1 2022.
53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.